Sampaio A.L., Mameri A.C., Vargas T.J. et al. Seborrheic dermatitis // An. Bras. Dermatol. 2011. Vol. 86. N. 6. P. 1061–1071. DOI: https://doi.org/10.1590/s0365-05962011000600002. PMID: 22281892.
Sauer G.C., Hall J.C. Manual of Skin Diseases. 7th ed. Lippincott Williams & Wilkins, 1996. 436 p.
Scaparro E., Quadri G., Virno G. et al. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil®) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial // Br. J. Dermatol. 2001. Vol. 144. N. 4. P. 854–857. DOI: https://doi.org/10.1046/j.1365-2133.2001.04144.x. PMID: 11298548.
Schwartz J.R., Messenger A.G., Tosti A. et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis — towards a more precise definition of scalp health // Acta Derm. Venereol. 2013. Vol. 93. N. 2. P. 131–137. DOI: https://doi.org/10.2340/00015555-1382. PMID: 22875203.
Schwartz R.A., Janusz C.A., Janniger C.K. Seborrheic dermatitis: an overview // Am. Fam. Physician. 2006. Vol. 74. N. 1. P. 125–130. PMID: 16848386.
Squire R.A., Goode K. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis // J. Dermatolog. Treat. 2002. Vol. 13. N. 2. P. 51–60. DOI: https://doi.org/10.1080/095466302317584395. PMID: 12060502.
Taieb A., Legrain V., Palmier C. et al. Topical ketoconazole for infantile seborrhoeic dermatitis // Dermatologica. 1990. Vol. 181. N. 1. P. 26–32. DOI: https://doi.org/10.1159/000247855. PMID: 2144249.
Unholzer A., Schinzel S., Nietsch K.-H. et al. Ciclopiroxolamine cream 1% in the treatment of seborrhoeic dermatitis: a double-blind, parallel-group comparison with ketoconazole and vehicle in a confirmatory trial // Clin. Drug. Invest. 2002. Vol. 22. N. 3. P. 167–172. DOI: https://doi.org/10.2165/00044011-200222030-00003. Epub 2012 Aug 24.
Victoire A., Magin P., Coughlan J., van Driel M.L. Interventions for infantile seborrhoeic dermatitis (including cradle cap) // Cochrane Database Syst. Rev. 2019. Issue 3. DOI: https://doi.org/10.1002/14651858.CD011380.pub2.
Wannanukul S., Chiabunkana J. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis // J. Med. Assoc. Thai. 2004. Vol. 87. Suppl. 2. P. S68–S71. PMID: 16083165.
Warshaw E.M., Wohlhuter R.J., Liu A. et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis // J. Am. Acad. Dermatol. 2007. Vol. 57. N. 2. P. 257–264. DOI: https://doi.org/10.1016/j.jaad.2006.11.007. PMID: 17188780.
&hide_Cookie=yes)